These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2854433)

  • 1. Should chemotherapy response be evaluated separately in sequential chemotherapy-radiotherapy schedules in locally advanced nonsmall-cell lung carcinoma?
    Thomas F; Le Chevalier T; Arriagada R; Ruffié P; Baldeyrou P
    Antibiot Chemother (1971); 1988; 41():138-41. PubMed ID: 2854433
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma.
    Le Chevalier T; Arriagada R; Quoix E; Ruffie P; Martin M; Douillard JY; Tarayre M; Lacombe-Terrier MJ; Laplanche A
    Lung Cancer; 1994 Mar; 10 Suppl 1():S239-44. PubMed ID: 8087515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent cisplatin-vindesine and hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer.
    Le Péchoux C; Arriagada R; Le Chevalier T; Bretel JJ; Cosset BP; Ruffié P; Baldeyrou P; Grunenwald D
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):519-25. PubMed ID: 8655375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.
    Arriagada R; Le Chevalier T; Quoix E; Ruffie P; de Cremoux H; Douillard JY; Tarayre M; Pignon JP; Laplanche A
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1183-90. PubMed ID: 1646194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study.
    Van Houtte P; Klastersky J; Renaud A; Michel J; Vandermoten G; Nguyen H; Sculier JP; Devriendt J; Mommen P
    Antibiot Chemother (1971); 1988; 41():131-7. PubMed ID: 2854432
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase III trial comparing docetaxel and cisplatin combination chemotherapy with mitomycin, vindesine, and cisplatin combination chemotherapy with concurrent thoracic radiotherapy in locally advanced non-small-cell lung cancer: OLCSG 0007.
    Segawa Y; Kiura K; Takigawa N; Kamei H; Harita S; Hiraki S; Watanabe Y; Sugimoto K; Shibayama T; Yonei T; Ueoka H; Takemoto M; Kanazawa S; Takata I; Nogami N; Hotta K; Hiraki A; Tabata M; Matsuo K; Tanimoto M
    J Clin Oncol; 2010 Jul; 28(20):3299-306. PubMed ID: 20530281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin, cisplatin, and vindesine followed by radiotherapy combined with cisplatin in stage III nonsmall cell lung cancer: long-term results.
    Tejedor M; Valerdi JJ; López R; Domínguez MA; Arias F; Illarramendi JJ; Martínez E
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):813-8. PubMed ID: 7860393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
    Mornex F
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
    Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Duroux P; Jacquotte A; Sancho-Garnier H; Rouesse J
    Cancer Treat Rep; 1985 May; 69(5):469-72. PubMed ID: 4039979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial].
    Nasr E; Pellae-Cosset B; Arriagada R; Le Chevalier T; Baldeyrou P; Ruffie P; de Cremoux H; Martin M; Tarayre M
    Bull Cancer; 1992; 79(7):681-7. PubMed ID: 1334740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study.
    Bonner JA; McGinnis WL; Stella PJ; Marschke RF; Sloan JA; Shaw EG; Mailliard JA; Creagan ET; Ahuja RK; Johnson PA
    Cancer; 1998 Mar; 82(6):1037-48. PubMed ID: 9506347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer.
    Furuse K; Fukuoka M; Kawahara M; Nishikawa H; Takada Y; Kudoh S; Katagami N; Ariyoshi Y
    J Clin Oncol; 1999 Sep; 17(9):2692-9. PubMed ID: 10561343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternating chemotherapy and accelerated split-course irradiation in locally advanced nonsmall cell lung carcinoma.
    Pignon T; Ruggieri S; Boutin C; Gouvernet J; Irisson M; Juin P; Astoul P
    Cancer; 1999 May; 85(10):2144-50. PubMed ID: 10326692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concurrent chemoradiotherapy using a single agent for unresectable stage III non-small cell lung cancer].
    Tamura A; Mikami A; Sagara Y; Hebisawa A
    Gan To Kagaku Ryoho; 2000 Oct; 27(11):1755-8. PubMed ID: 11057330
    [No Abstract]   [Full Text] [Related]  

  • 15. Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.
    Athanassiades P; Lagoudis M; Kostis E
    J Chemother; 1989 Jul; 1(4 Suppl):1205-6. PubMed ID: 16312835
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non-small cell lung cancer.
    Pisters KM; Kris MG; Gralla RJ; Hilaris B; McCormack PM; Bains MS; Martini N
    J Surg Oncol; 1994 Aug; 56(4):236-41. PubMed ID: 8057649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial tumor size and local control in stage III non-small cell lung cancer treated by radio-chemotherapy.
    Karstens JH; Andreopoulos D; Ammon J
    Onkologie; 1990 Apr; 13(2):144-5. PubMed ID: 2165229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non small cell lung cancer and chemotherapy.
    Nardini S
    Monaldi Arch Chest Dis; 1994 Apr; 49(2):177-8. PubMed ID: 8049706
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined intra-arterial chemotherapy and radiotherapy in inoperable non-small cell bronchial carcinoma].
    Rieber A; Brambs HJ; Kauffmann G; Wannenmacher M; Drings P
    Strahlenther Onkol; 1991 Jan; 167(1):14-8. PubMed ID: 1846982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of unresectable nonsmall-cell lung cancer (NSCLC).
    Papacharalambous A; Rigatos G; Alexopoulos A; Stavrakakis J; Scartsilas C; Stavrinidis E
    J Chemother; 1989 Jul; 1(4 Suppl):1214-5. PubMed ID: 16312839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.